脱:从调节机制到癌症癌症的临床影响
Ming Zhang1, Peng Qiu1, Yunxiang Feng1
1Department of Biliary and Pancreatic Surgery, Cancer Research Center Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, Hubei Province, China.
缩,一个关键的癌症途径,通过改变蛋白质稳定性和细胞信号传递驱动瘤生长. 通过像MLN4924这样的药物准这个过程,为精密瘤学提供了有前途的治疗策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 缩是一种关键的翻译后修改,在人类癌症中经常过度激活.
- 这条通路调节蛋白质的稳定性,细胞信号传递和生物过程.
- 度失调驱动瘤发生和进展,使其成为治疗点.
研究的目的:
- 阐明缩过程和调节机制.
- 详细说明缩如何促进癌症的特征和恶性进展.
- 审查针对缩的药物,临床进展以及精密瘤学的未来前景.
主要方法:
- 系统性审查的病原性网络的脱.
- 在癌症特征中的分子基础的分析.
- 针对性治疗策略和临床证据的评估.
主要成果:
- 缩调节蛋白质功能和细胞活动,控制癌症的关键特征.
- 药物开发正在推进,其目标是缩成分.
- 像MLN4924和TAS4464这样的抑制剂显示出临床潜力.
结论:
- 缩是癌症发病的一个中心途径.
- 对抗缩的向疗法是癌症治疗的一个有希望的途径.
- 进一步的研究和临床试验对于针对缩的精密瘤学至关重要.
更多相关视频
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
08:12Utilizing a Comprehensive Immunoprecipitation Enrichment System to Identify an Endogenous Post-translational Modification Profile for Target Proteins
Published on: January 8, 2018
相关概念视频
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Biosynthesis of Nucleic Acids
Abnormal Proliferation
